Products / PRODUCT LIST

API PRODUCTS PORTFOLIO

Inke's products are high-added-value active pharmaceutical ingredients (APIs),
mainly for use in respiratory inhalation and CNS therapies

API	Indication	Micronised	CEP	EU DMF	US DMF	JP DMF	KR DMF	CN DMF
Ondansetron hydrochloride^p	Emesis		•		•
Otilonium bromide	Irritable bowel syndrome			•
Prasugrel base^p	Prophylaxis and therapy of thrombosis			•
Quetiapine hemifumarate^p	Schizophrenia, psychosis			•		•	•
Risperidone^p	Schizophrenia, psychosis	•	•		•		•
Rivaroxaban	Thrombosis. Stroke			•
Rizatriptan benzoate^p	Migraine	•		•	•
Salmeterol xinafoate^p	Asthma and COPD	•	•		•		•	•
Tetrabenazine	Huntington's disease chorea and Tardive dyskinesia			•	•
Tiotropium bromide	COPD	•	•		•			•
Vilanterol trifenatate	Asthma and COPD	•		•	•
Zolmitriptan^p	Migraine	•		•	•

DOWNLOAD INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.